UPDATE : Thursday, September 19, 2019
상단여백
Helixmith unveils results for neuromuscular disease treatment by Lee Han-soo 2019-08-02 17:52
‘MSD Korea playing tricks to maintain monitoring on salespersons’ by Kim Yun-mi 2019-08-02 15:48
Conflict erupts between employees of Takeda, Shire during merger by Kim Yun-mi 2019-08-02 14:23
Sillajen likely to scrap global P3 trials for Pexa-Vec by Lee Han-soo 2019-08-02 10:29
KAIST-Hanyang University team presents new anticancer principle by Lee Han-soo 2019-08-01 17:30
라인
Health ministry to reimburse Novartis’ Revolade treating severe aplastic anemia by Lee Han-soo 2019-08-01 13:36
New weight loss drug Qsymia wins local approval by Lee Hye-seon 2019-08-01 10:57
‘Hanmi’s Carnitil improves cognitive function in patients’ by Lee Han-soo 2019-07-31 17:05
Hanall marks record sales in Q2 by Lee Han-soo 2019-07-31 17:00
Novartis fails to expand heart failure drug Entresto’s indication by Kim Yun-mi 2019-07-31 14:26
라인
Hanmi marks ₩270.4 billion in Q2 sales by Lee Han-soo 2019-07-30 17:26
Kolmar Korea boosts beauty, health biz through acquisitions by Park Gi-taek 2019-07-30 14:43
GC’s Chinese partner applies for Hunter syndrome drug’s sales approval by Lee Han-soo 2019-07-30 10:49
‘FDA likely to OK 11 blockbuster candidates in August’ by Kim Yun-mi 2019-07-29 16:55
Top-30 makers produce more than half of drugs by Lee Hye-seon 2019-07-29 16:38
라인
Takeda’s Zejula poised to change local ovarian cancer treatment market by Kim Yun-mi 2019-07-29 12:04
Court extends ‘temporary suspension’ of order to cancel Invossa trials by Jeong Sae-im 2019-07-26 17:50
SNUBH professor is 1st Asian keynoter at international Alzheimer meet by Lee Han-soo 2019-07-26 16:08
‘Kolon Life Science to start following up on Invossa-treated patients’ by Lee Han-soo 2019-07-26 12:21
JW Creagene wins US patent for making dendritic cell treatment by Lee Han-soo 2019-07-25 16:39
여백
여백
여백
Back to Top